Related references
Note: Only part of the references are listed.Redirecting macrophage function to sustain their defender'' antitumor activity
Stephanie L. Tzetzo et al.
CANCER CELL (2021)
CD47: role in the immune system and application to cancer therapy
Seyed Mohammad Gheibi Hayat et al.
CELLULAR ONCOLOGY (2020)
M2-like polarization of THP-1 monocyte-derived macrophages under chronic iron overload
Jun-Kai Kao et al.
ANNALS OF HEMATOLOGY (2020)
Targeting CD47 as a Novel Immunotherapy for Multiple Myeloma
Jennifer Sun et al.
CANCERS (2020)
The future of cancer immunotherapy: microenvironment-targeting combinations
Yonina R. Murciano-Goroff et al.
CELL RESEARCH (2020)
Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity
Christina A. von Roemeling et al.
NATURE COMMUNICATIONS (2020)
Dual P-Glycoprotein and CA XII Inhibitors: A New Strategy to Reverse the P-gp Mediated Multidrug Resistance (MDR) in Cancer Cells
Elisabetta Teodori et al.
MOLECULES (2020)
CD47: the next checkpoint target for cancer immunotherapy
Ridong Feng et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Multispecific Platinum(IV) Complex Deters Breast Cancer via Interposing Inflammation and Immunosuppression as an Inhibitor of COX-2 and PD-L1
Suxing Jin et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Tolerance in the Age of Immunotherapy
Jeffrey A. Bluestone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
MiR-148a Affects Polarization of THP-1-Derived Macrophages and Reduces Recruitment of Tumor-Associated Macrophages via Targeting SIRPα
Donghe Ma et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Interfering in apoptosis and DNA repair of cancer cells to conquer cisplatin resistance by platinum(iv) prodrugs
Shuren Zhang et al.
CHEMICAL SCIENCE (2020)
Synthesis and evaluation of bi-functional 7-hydroxycoumarin platinum(IV) complexes as antitumor agents
Qingpeng Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Natural Killer Cell Recruitment and Activation Are Regulated by CD47 Expression in the Tumor Microenvironment
Pulak Ranjan Nath et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Checkpoint CD47 Function On Tumor Metastasis And Immune Therapy
Shu Lian et al.
ONCOTARGETS AND THERAPY (2019)
Stimuli-Responsive Therapeutic Metallodrugs
Xiaohui Wang et al.
CHEMICAL REVIEWS (2019)
Metal Drugs and the Anticancer Immune Response
Bernhard Englinger et al.
CHEMICAL REVIEWS (2019)
Oxaliplatin regulates myeloid-derived suppressor cell-mediated immunosuppression via downregulation of nuclear factor-κB signaling
Na-Rae Kim et al.
CANCER MEDICINE (2019)
CD20-selective inhibition of CD47-SIRP alpha don't eat me signaling with a bispecific antibody-derivative enhances the anticancer activity of daratumumab, alemtuzumab and obinutuzumab
Peter E. van Bommel et al.
ONCOIMMUNOLOGY (2018)
A Cisplatin-Loaded Immunochemotherapeutic Nanohybrid Bearing Immune Checkpoint Inhibitors for Enhanced Cervical Cancer Therapy
Na Wang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
4Mu Decreases CD47 Expression on Hepatic Cancer Stem Cells and Primes a Potent Antitumor T Cell Response Induced by Interleukin-12
Marcelo M. Rodriguez et al.
MOLECULAR THERAPY (2018)
Targeting macrophages: therapeutic approaches in cancer
Luca Cassetta et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer
Hanke L. Matlung et al.
IMMUNOLOGICAL REVIEWS (2017)
THP-1 and human peripheral blood mononuclear cell-derived macrophages differ in their capacity to polarize in vitro
Hiromi Shiratori et al.
MOLECULAR IMMUNOLOGY (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
TIGIT: A Key Inhibitor of the Cancer Immunity Cycle
Nicholas A. Manieri et al.
TRENDS IN IMMUNOLOGY (2017)
Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma
Linda Tran et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Modulation of antitumor immunity contributes to the enhanced therapeutic efficacy of liposomal oxaliplatin in mouse model
Taro Shimizu et al.
CANCER SCIENCE (2017)
Cytokines in immunogenic cell death: Applications for cancer immunotherapy
Anne Showalter et al.
CYTOKINE (2017)
The choice of phorbol 12-myristate 13-acetate differentiation protocol influences the response of THP-1 macrophages to a pro-inflammatory stimulus
Maria E. Lund et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2016)
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
Lorenzo Galluzzi et al.
CANCER CELL (2015)
Molecular Pathways: Activating T Cells after Cancer Cell Phagocytosis from Blockade of CD47 Don't Eat Me Signals
Melissa N. McCracken et al.
CLINICAL CANCER RESEARCH (2015)
Synthetic Methods for the Preparation of Platinum Anticancer Complexes
Justin J. Wilson et al.
CHEMICAL REVIEWS (2014)
From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation
Paola Italiani et al.
FRONTIERS IN IMMUNOLOGY (2014)
Dose-Dense Chemotherapy Improves Mechanisms of Antitumor Immune Response
Chih-Long Chang et al.
CANCER RESEARCH (2013)
Influence of Equatorial and Axial Carboxylato Ligands on the Kinetic Inertness of Platinum(IV) Complexes in the Presence of Ascorbate and Cysteine and within DLD-1 Cancer Cells
Catherine K. J. Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response
Diane Tseng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
Stephen B. Willingham et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Tumor-targeting magnetic lipoplex delivery of short hairpin RNA suppresses IGF-1R overexpression of lung adenocarcinoma A549 cells in vitro and in vivo
Chunmao Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice
W. Joost Lesterhuis et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Cisplatin primes murine peritoneal macrophages for enhanced expression of nitric oxide, proinflammatory cytokines, TLRs, transcription factors and activation of MAP kinases upon co-incubation with L929 cells
Puja Chauhan et al.
IMMUNOBIOLOGY (2009)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Cellular processing of platinum anticancer drugs
D Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-α:: Down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation
S Latour et al.
JOURNAL OF IMMUNOLOGY (2001)
CD47-signal regulatory protein α (SIRPα) regulates Fcγ and complement receptor-mediated phagocytosis
PA Oldenborg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
CD47 engagement inhibits cytokine production and maturation of human dendritic cells
CE Demeure et al.
JOURNAL OF IMMUNOLOGY (2000)